Progression rate of newly diagnosed impaired fasting glycemia to type 2 diabetes mellitus: A study using the National Healthcare Group Diabetes Registry in Singapore

Journal of Diabetes

Volumn 4, Issue 2, 2012, Pages 159-163

  Ang, Yee Gary ^a   Wu, Christine Xia ^a   Toh, Matthias Paul Han Sim ^a   Chia, Kee Seng ^b   Heng, Bee Hoon ^a  

^a NATIONAL HEALTHCARE GROUP   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Diabetes mellitus; Impaired fasting glycemia; Singapore

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BODY MASS; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE REGISTRY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED FASTING GLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; SINGAPORE; SURVIVAL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLUCOSE METABOLISM DISORDERS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SINGAPORE; TIME FACTORS;

EID: 84861180828     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2011.00169.x     Document Type: Article

References (17)

1. Epidemiology and Disease Control Division, Ministry of Health. National Health Survey 2004. Ministry of Health, Singapore, 2004.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4-14.
3. Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care. 2007; 30: 228-33.
4. Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3year follow-up in the ADDITION study, Denmark. Diabetologia. 2008; 51: 249-57.
5. Chen KT, Chen CJ, Gregg EW, Imperatore G, Narayan KM. Impaired fasting glucose and risk of diabetes in Taiwan: Follow-up over 3years. Diabetes Res Clin Pract. 2003; 60: 177-82.
6. Ko GT, Chan JC, Cockram CS. Change of glycaemic status in Chinese subjects with impaired fasting glycaemia. Diabet Med. 2001; 18: 745-8.
7. Gerstein HC, Santaguida P, Raina P et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007; 78: 305-12.
8. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care. 2000; 23: 1770-3.
9. Vermes E, Ducharme A, Bourassa MG et al. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: Insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation. 2003; 107: 1291-6.
10. Keech A, Colquhoun D, Best J et al. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: Results from the LIPID trial. Diabetes Care. 2003; 26: 2713-21.
11. de Vegt F, Dekker JM, Jager A et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA. 2001; 285: 2109-13.
12. Dinneen SF, Maldonado D, Leibson CL et al. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care. 1998; 21: 1408-13.
13. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R; Baltimore Longitudinal Study of Aging. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes. 2003; 52: 1475-84.
14. Heng BH, Sun Y, Cheah JT, Jong M. The Singapore National Healthcare Group Diabetes Registry: Descriptive epidemiology of type 2 diabetes mellitus. Ann Acad Med Singapore. 2010; 39: 348-52.
15. National Healthcare Group. Clinical Guidelines for Primary Care, 4th edn. National Healthcare Group, Singapore, 2010.
16. Lindström J, Ilanne-Parikka P, Peltonen M et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006; 368: 1673-9.
17. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403.